282 related articles for article (PubMed ID: 20816719)
1. Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity.
Hoffmann D; Fuchs TC; Henzler T; Matheis KA; Herget T; Dekant W; Hewitt P; Mally A
Toxicology; 2010 Nov; 277(1-3):49-58. PubMed ID: 20816719
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin a in vivo and in vitro.
Rached E; Hoffmann D; Blumbach K; Weber K; Dekant W; Mally A
Toxicol Sci; 2008 Jun; 103(2):371-81. PubMed ID: 18308701
[TBL] [Abstract][Full Text] [Related]
3. Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat.
Harpur E; Ennulat D; Hoffman D; Betton G; Gautier JC; Riefke B; Bounous D; Schuster K; Beushausen S; Guffroy M; Shaw M; Lock E; Pettit S;
Toxicol Sci; 2011 Aug; 122(2):235-52. PubMed ID: 21593213
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the relative performance of 12 urinary biomarkers for renal safety across 22 rat sensitivity and specificity studies.
Vlasakova K; Erdos Z; Troth SP; McNulty K; Chapeau-Campredon V; Mokrzycki N; Muniappa N; Gu YZ; Holder D; Bailey WJ; Sistare FD; Glaab WE
Toxicol Sci; 2014 Mar; 138(1):3-20. PubMed ID: 24361871
[TBL] [Abstract][Full Text] [Related]
5. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury.
Ichimura T; Hung CC; Yang SA; Stevens JL; Bonventre JV
Am J Physiol Renal Physiol; 2004 Mar; 286(3):F552-63. PubMed ID: 14600030
[TBL] [Abstract][Full Text] [Related]
6. Urinary cystatin C as a biomarker for acute kidney injury and its immunohistochemical localization in kidney in the CDDP-treated rats.
Togashi Y; Sakaguchi Y; Miyamoto M; Miyamoto Y
Exp Toxicol Pathol; 2012 Nov; 64(7-8):797-805. PubMed ID: 21377848
[TBL] [Abstract][Full Text] [Related]
7. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury.
Waring WS; Moonie A
Clin Toxicol (Phila); 2011 Oct; 49(8):720-8. PubMed ID: 21970770
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the course of biomarker changes and kidney injury in a rat model of drug-induced acute kidney injury.
Sasaki D; Yamada A; Umeno H; Kurihara H; Nakatsuji S; Fujihira S; Tsubota K; Ono M; Moriguchi A; Watanabe K; Seki J
Biomarkers; 2011 Nov; 16(7):553-66. PubMed ID: 21955166
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of novel acute urinary rat kidney toxicity biomarker for subacute toxicity studies in preclinical trials.
Fuchs TC; Frick K; Emde B; Czasch S; von Landenberg F; Hewitt P
Toxicol Pathol; 2012 Oct; 40(7):1031-48. PubMed ID: 22581810
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of collecting duct injury in Han-Wistar and Sprague-Dawley rats treated with N-phenylanthranilic Acid.
Betton GR; Ennulat D; Hoffman D; Gautier JC; Harpur E; Pettit S
Toxicol Pathol; 2012 Jun; 40(4):682-94. PubMed ID: 22301952
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of novel biomarkers of nephrotoxicity in two strains of rat treated with Cisplatin.
Gautier JC; Riefke B; Walter J; Kurth P; Mylecraine L; Guilpin V; Barlow N; Gury T; Hoffman D; Ennulat D; Schuster K; Harpur E; Pettit S
Toxicol Pathol; 2010 Oct; 38(6):943-56. PubMed ID: 20716785
[TBL] [Abstract][Full Text] [Related]
12. Urinary cystatin C as a renal biomarker and its immunohistochemical localization in anti-GBM glomerulonephritis rats.
Togashi Y; Imura N; Miyamoto Y
Exp Toxicol Pathol; 2013 Nov; 65(7-8):1137-43. PubMed ID: 23791361
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of novel renal biomarkers with a cisplatin model of kidney injury: gender and dosage differences.
Pinches M; Betts C; Bickerton S; Burdett L; Thomas H; Derbyshire N; Jones HB; Moores M
Toxicol Pathol; 2012 Apr; 40(3):522-33. PubMed ID: 22491933
[TBL] [Abstract][Full Text] [Related]
14. Urinary cystatin C as a biomarker for diabetic nephropathy and its immunohistochemical localization in kidney in Zucker diabetic fatty (ZDF) rats.
Togashi Y; Miyamoto Y
Exp Toxicol Pathol; 2013 Jul; 65(5):615-22. PubMed ID: 22795897
[TBL] [Abstract][Full Text] [Related]
15. Time course of renal proximal tubule injury, reversal, and related biomarker changes in rats following cisplatin administration.
McDuffie JE; Ma JY; Sablad M; Sonee M; Varacallo L; Louden C; Guy A; Vegas J; Liu X; La D; Snook S
Int J Toxicol; 2013 Jul; 32(4):251-60. PubMed ID: 23788329
[TBL] [Abstract][Full Text] [Related]
16. Kidney injury biomarkers in hypertensive, diabetic, and nephropathy rat models treated with contrast media.
Rouse RL; Stewart SR; Thompson KL; Zhang J
Toxicol Pathol; 2013; 41(4):662-80. PubMed ID: 23085980
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the MesoScale Discovery and Luminex multiplex platforms for measurement of urinary biomarkers in a cisplatin rat kidney injury model.
Pavkovic M; Riefke B; Gutberlet K; Raschke M; Ellinger-Ziegelbauer H
J Pharmacol Toxicol Methods; 2014; 69(2):196-204. PubMed ID: 24333954
[TBL] [Abstract][Full Text] [Related]
18. Tissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in rats.
Vinken P; Starckx S; Barale-Thomas E; Looszova A; Sonee M; Goeminne N; Versmissen L; Buyens K; Lampo A
Toxicol Pathol; 2012 Oct; 40(7):1049-62. PubMed ID: 22581811
[TBL] [Abstract][Full Text] [Related]
19. Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers.
Keirstead ND; Wagoner MP; Bentley P; Blais M; Brown C; Cheatham L; Ciaccio P; Dragan Y; Ferguson D; Fikes J; Galvin M; Gupta A; Hale M; Johnson N; Luo W; McGrath F; Pietras M; Price S; Sathe AG; Sasaki JC; Snow D; Walsky RL; Kern G
Toxicol Sci; 2014 Feb; 137(2):278-91. PubMed ID: 24189134
[TBL] [Abstract][Full Text] [Related]
20. Tissue expression and correlation of a panel of urinary biomarkers following cisplatin-induced kidney injury.
Wadey RM; Pinches MG; Jones HB; Riccardi D; Price SA
Toxicol Pathol; 2014; 42(3):591-602. PubMed ID: 23823703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
